The Secaucus-based firm, which trades on the NYSE under the ticker DGX, maintains a significant footprint in the American healthcare landscape. By providing laboratory insights to approximately half of the nation's physicians and hospitals, the company processes testing for one in three U.S. adults annually. Its current workforce of nearly 60,000 employees continues to focus on diagnostic simplification to aid disease identification and patient management.